Relypsa, Inc.

Relypsa, Inc.

Relypsa, Inc.

Overview
Date Founded

2007

Headquarters

100 CARDINAL WAY, REDWOOD CITY, CA, 94063

Type of Company

Private

Employees (Worldwide)

501 - 1,000

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Relypsa, Inc. operates as a bio-pharmaceutical company, which is focused on the development and commercialization of polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Data
Trying to get in touch with decision makers at Relypsa, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President

Executive Director of Information Technology

Senior Vice President, General Counsel & Head of US Site Operations

Vice President, Commercial

Vice President of Technical Operations

Vice President, Finance

Executive Director

Executive Director

Account Executive

Senior Director

Paths to Relypsa, Inc.
Potential Connections via
Relationship Science
You
Relypsa, Inc.
Recent Transactions
Details Hidden

Vifor Pharma AG purchases Relypsa, Inc.

Details Hidden

Relypsa, Inc. issued Common Stock

Details Hidden

Relypsa, Inc. issued Common Stock

Transaction Advisors
Investment Advisor

Advised onVifor Pharma AG purchases Relypsa, Inc.

Escrow Agent

Advised onRelypsa, Inc. issued Common Stock

Underwriter

Advised onRelypsa, Inc. issued Common Stock

Associate

Advised onVifor Pharma AG purchases Relypsa, Inc.

Legal Advisor

Advised onVifor Pharma AG purchases Relypsa, Inc.

Associate

Advised onVifor Pharma AG purchases Relypsa, Inc.

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Consultant

Chief Executive Officer & President at Tricida, Inc.

Clients

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

Key Stats and Financials As of
Market Capitalization
$1.44B
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

Amgen Ventures LLC invests in biotechnology companies located in North America, Europe and the UK. It focuses companies operating in the fields of discovering and developing human therapeutics. It make financing for early stage capital requirements and invests up to $3 to $5 million per round with $15 million over the life of the company.

Details Hidden

Senior Vice President, Regulatory Affairs at Steadymed Therapeutics, Inc.

Details Hidden

Chief Medical Officer at Satsuma Pharmaceuticals, Inc.

Suppliers
Lanxess AG Plastics & Synthetics | Cologne, NW

LANXESS AG is a holding company, which engages in the provision of specialty chemicals. It operates through the following segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, High Performance Materials, and Arlanxeo. The Advanced Intermediates segment consists of industrial chemical intermediates and a key player in the custom synthesis, and manufacturing of chemical precursors and specialty active ingredients. The Specialty Additives segment focuses on specialty additive chemicals. The Performance Chemicals segment covers application-oriented process, and functional chemicals operations. The High Performance Materials segment represents plastic activities in the engineering materials. The Arlanxeo segment refers to synthetic rubber activities. The company was founded on July 1, 2004 and is headquartered in Leverkusen, Germany.

Sanofi Pharmaceuticals | Paris, IF

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Thermo Fisher Scientific, Inc. Computer Software | Waltham, Massachusetts

Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.

Competitors
AstraZeneca Plc Pharmaceuticals - Cambridge, CA

AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Ardelyx, Inc. Pharmaceuticals - FREMONT , CA

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of renal diseases. It focuses on the formulation of programs directed toward treating gastrointestinal and irritable bowel syndrome with constipations. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Relypsa, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Relypsa, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Relypsa, Inc..